- Home
- SIBN vs PSNL Comparison
SIBN vs PSNL Comparison
Compare SIBN & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIBN
- PSNL
- Stock Information
- Founded
- SIBN 2008
- PSNL 2011
- Country
- SIBN United States
- PSNL United States
- Employees
- SIBN N/A
- PSNL N/A
- Industry
- SIBN Medical/Dental Instruments
- PSNL Medical Specialities
- Sector
- SIBN Health Care
- PSNL Health Care
- Exchange
- SIBN Nasdaq
- PSNL Nasdaq
- Market Cap
- SIBN 547.3M
- PSNL 460.7M
- IPO Year
- SIBN 2018
- PSNL 2019
- Fundamental
- Price
- SIBN $16.69
- PSNL $4.89
- Analyst Decision
- SIBN Strong Buy
- PSNL Strong Buy
- Analyst Count
- SIBN 6
- PSNL 4
- Target Price
- SIBN $23.00
- PSNL $8.56
- AVG Volume (30 Days)
- SIBN 338.4K
- PSNL 1.5M
- Earning Date
- SIBN 02-24-2025
- PSNL 02-26-2025
- Dividend Yield
- SIBN N/A
- PSNL N/A
- EPS Growth
- SIBN N/A
- PSNL N/A
- EPS
- SIBN N/A
- PSNL N/A
- Revenue
- SIBN $157,035,000.00
- PSNL $87,489,000.00
- Revenue This Year
- SIBN $21.24
- PSNL $15.76
- Revenue Next Year
- SIBN $17.40
- PSNL $4.90
- P/E Ratio
- SIBN N/A
- PSNL N/A
- Revenue Growth
- SIBN 18.98
- PSNL 24.05
- 52 Week Low
- SIBN $11.70
- PSNL $1.12
- 52 Week High
- SIBN $21.64
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- SIBN 67.93
- PSNL 45.39
- Support Level
- SIBN $15.88
- PSNL $5.22
- Resistance Level
- SIBN $16.60
- PSNL $5.50
- Average True Range (ATR)
- SIBN 0.91
- PSNL 0.57
- MACD
- SIBN 0.31
- PSNL -0.18
- Stochastic Oscillator
- SIBN 86.86
- PSNL 8.33
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.